Insights on the Performance of Phenotypic Tests Versus Genotypic Tests for the Detection of Carbapenemase-producing Gram-negative Bacilli in Resource-limited Settings

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2022 Oct 13

PMID 36229768

Authors

Noha A Kamel

Sally T Tohamy

Ibrahim S Yahia

Khaled M Aboshanab

Affiliations

Soon will be listed here.

Abstract

Background: Carbapenemase-producing Gram-negative (CPGN) bacteria impose life-threatening infections with limited treatment options. Rigor and rapid detection of CPGN-associated infections is usually associated with proper treatment and better disease prognosis. Accordingly, this study aimed at evaluating the phenotypic methods versus genotypic methods used for the detection of such pathogens and determining their sensitivity/specificity values.

Methods: A total of 71 CPGN bacilli (30 Enterobacterales and 41 non-glucose-fermenting bacilli) were tested for the carbapenemase production by the major phenotypic approaches including, the modified Hodge test (MHT), modified carbapenem inactivation method (mCIM), combined disk test by EDTA (CDT) and blue-carba test (BCT). The obtained results were statistically analyzed and correlated to the obtained resistant genotypes that were determined by using polymerase chain reactions (PCR) for the detection of the major carbapenemase-encoding genes covering the three classes (Class A, B, and D) of carbapenemases.

Results: In comparison to PCR, the overall sensitivity/specificity values for detection of carbapenemase-producing organism were 65.62%/100% for MHT, 68.65%/100% for mCIM, 55.22%/100% for CDT and 89.55%/75% for BCT. The sensitivity/specificity values for carbapenemase-producing Enterobacterales were, 74%100% for MHT, 51.72%/ 100% for mCIM, 62.07%/100% for CDT and 82.75%/100% for BCT. The sensitivity/specificity values for carbapenemase-producing non-glucose fermenting bacilli were, 62.16%/100% for MHT, 81.57%/100% for mCIM, 50/100% for CDT and 94.74%/66.66% for BCT. Considering these findings, BCT possess a relatively high performance for the efficient and rapid detection of carbapenemase producing isolates. Statistical analysis showed significant association (p < 0.05) between bla and/or bla genotypes with MHT/CDT; bla/bla genotypes with CDT and bla genotype with BCT.

Conclusion: The current study provides an update on the performance of the phenotypic tests which are varied depending on the tested bacterial genera and the type of the carbapenemase. The overall sensitivity/specificity values for detection of CPO were 65.62%/100% for MHT, 68.65%/100% for mCIM, 55.22%/100% for CDT and 89.55%/75% for BCT. Based on its respective diagnostic efficiency and rapid turnaround time, BCT is more likely to be recommended in a resource-limited settings particularly, when molecular tests are not available.

Citing Articles

Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience.

Novazzi F, Arcari G, Ferrante F, Boutahar S, Genoni A, Carcione D Diagnostics (Basel). 2024; 14(15).

PMID: 39125475 PMC: 11311838. DOI: 10.3390/diagnostics14151599.

Evaluation of fortimicin antibiotic combinations against MDR Pseudomonas aeruginosa and resistome analysis of a whole genome sequenced pan-drug resistant isolate.

Kamel N, Tohamy S, Alshahrani M, Aboshanab K BMC Microbiol. 2024; 24(1):164.

PMID: 38745145 PMC: 11092080. DOI: 10.1186/s12866-024-03316-2.

Prevalence of Antimicrobial Resistance Among the Hydrogen Sulfide Producing Bacteria Isolated on XLD Agar from the Poultry Fecal Samples.

Mathew M, Afthab M, S S, C S, Mathew J, E K R Appl Biochem Biotechnol. 2023; 196(4):2318-2331.

PMID: 37540287 DOI: 10.1007/s12010-023-04633-4.

Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin.

Mabrouk S, Abdellatif G, Abu Zaid A, Aboshanab K BMC Microbiol. 2023; 23(1):195.

PMID: 37481513 PMC: 10362616. DOI: 10.1186/s12866-023-02934-6.

Transferable IncX3 plasmid harboring bla, ble, and aph(3')-VI genes from Klebsiella pneumoniae conferring phenotypic carbapenem resistance in E. coli.

Elshamy A, Saleh S, Aboshanab K, Aboulwafa M, Hassouna N Mol Biol Rep. 2023; 50(6):4945-4953.

PMID: 37081308 PMC: 10209314. DOI: 10.1007/s11033-023-08401-9.

References

Tamma P, Wang R, Lewis S, Opene B, Simner P . Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?. Infect Control Hosp Epidemiol. 2017; 38(11):1378-1379. PMC: 5748885. DOI: 10.1017/ice.2017.210. View

Elshamy A, Saleh S, Alshahrani M, Aboshanab K, Aboulwafa M, Hassouna N . OXA-48 Carbapenemase-Encoding Transferable Plasmids of Recovered from Egyptian Patients Suffering from Complicated Urinary Tract Infections. Biology (Basel). 2021; 10(9). PMC: 8469419. DOI: 10.3390/biology10090889. View

Ramsamy Y, Mlisana K, Amoako D, Abia A, Ismail A, Allam M . Mobile genetic elements-mediated Enterobacterales-associated carbapenemase antibiotic resistance genes propagation between the environment and humans: A One Health South African study. Sci Total Environ. 2021; 806(Pt 3):150641. DOI: 10.1016/j.scitotenv.2021.150641. View

Mabrouk S, Abdellatif G, El-Ansary M, Aboshanab K, Ragab Y . Carbapenemase Producers Among Extensive Drug-Resistant Gram-Negative Pathogens Recovered from Febrile Neutrophilic Patients in Egypt. Infect Drug Resist. 2020; 13:3113-3124. PMC: 7495499. DOI: 10.2147/IDR.S269971. View

Ma C, Ng K, Yam B, Ho P, Kao R, Yang D . Rapid Broad Spectrum Detection of Carbapenemases with a Dual Fluorogenic-Colorimetric Probe. J Am Chem Soc. 2021; 143(18):6886-6894. DOI: 10.1021/jacs.1c00462. View

Kopotsa K, Osei Sekyere J, Mbelle N . Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review. Ann N Y Acad Sci. 2019; 1457(1):61-91. DOI: 10.1111/nyas.14223. View

Makharita R, El-Kholy I, Hetta H, Abdelaziz M, Hagagy F, Ahmed A . Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections. Infect Drug Resist. 2020; 13:3991-4002. PMC: 7649219. DOI: 10.2147/IDR.S276975. View

Moawad A, Hotzel H, Hafez H, Ramadan H, Tomaso H, Braun S . Occurrence, Phenotypic and Molecular Characteristics of Extended-Spectrum Beta-Lactamase-Producing in Healthy Turkeys in Northern Egypt. Antibiotics (Basel). 2022; 11(8). PMC: 9404839. DOI: 10.3390/antibiotics11081075. View

Otsuka Y . Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria. Chem Pharm Bull (Tokyo). 2020; 68(3):182-190. DOI: 10.1248/cpb.c19-00842. View

10.

Zhang Z, Wang D, Li Y, Liu Y, Qin X . Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice. Front Cell Infect Microbiol. 2022; 12:849564. PMC: 8899507. DOI: 10.3389/fcimb.2022.849564. View

11.

Pancotto L, Silva Nodari C, Rozales F, Soldi T, Siqueira C, Freitas A . Performance of rapid tests for carbapenemase detection among Brazilian Enterobacteriaceae isolates. Braz J Microbiol. 2018; 49(4):914-918. PMC: 6175730. DOI: 10.1016/j.bjm.2018.07.002. View

12.

Naim H, Rizvi M, Gupta R, Azam M, Taneja N, Shukla I . Drug Resistance and Molecular Epidemiology of Carbapenem Resistant Gram-negative Bacilli Isolates. J Glob Infect Dis. 2018; 10(3):133-139. PMC: 6100334. DOI: 10.4103/jgid.jgid_74_17. View

13.

Kidd J, Livermore D, Nicolau D . The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases. Clin Microbiol Infect. 2020; 26(4):401-403. DOI: 10.1016/j.cmi.2019.12.006. View

14.

Chia P, Sengupta S, Kukreja A, S L Ponnampalavanar S, Ng O, Marimuthu K . The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms. Antimicrob Resist Infect Control. 2020; 9(1):29. PMC: 7014667. DOI: 10.1186/s13756-020-0685-1. View

15.

He J, Du X, Zeng X, Moran R, van Schaik W, Zou Q . Phenotypic and Genotypic Characterization of a Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae ST17-KL38 Clinical Isolate Harboring the Carbapenemase IMP-4. Microbiol Spectr. 2022; 10(2):e0213421. PMC: 9045192. DOI: 10.1128/spectrum.02134-21. View

16.

Wilson G, Suda K, Fitzpatrick M, Bartle B, Pfeiffer C, Jones M . Risk Factors Associated With Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Positive Cultures in a Cohort of US Veterans. Clin Infect Dis. 2021; 73(8):1370-1378. DOI: 10.1093/cid/ciab415. View

17.

Meier M, Hamprecht A . Systematic Comparison of Four Methods for Detection of Carbapenemase-Producing Directly from Blood Cultures. J Clin Microbiol. 2019; 57(11). PMC: 6813004. DOI: 10.1128/JCM.00709-19. View

18.

Kuchibiro T, Komatsu M, Yamasaki K, Nakamura T, Nishio H, Kimura K . Comparison of the performance of three carbapenem inactivation methods for the detection of carbapenemase-producing gram-negative bacilli. J Infect Chemother. 2021; 27(11):1634-1638. DOI: 10.1016/j.jiac.2021.07.021. View

19.

Mojica M, Rossi M, Vila A, Bonomo R . The urgent need for metallo-β-lactamase inhibitors: an unattended global threat. Lancet Infect Dis. 2021; 22(1):e28-e34. PMC: 8266270. DOI: 10.1016/S1473-3099(20)30868-9. View

20.

Hadjadj L, Ali Syed M, Abbasi S, Rolain J, Jamil B . Diversity of Carbapenem Resistance Mechanisms in Clinical Gram-Negative Bacteria in Pakistan. Microb Drug Resist. 2020; 27(6):760-767. DOI: 10.1089/mdr.2019.0387. View